Circa Group AS

Circa Group AS Net Debt

Delisted

The Net Debt of Circa Group AS (CIRCA.OL) as of Oct 23, 2026 is -11.33 M EUR. In the previous year, Net Debt was -34.71 M EUR — a change of -67.35% (higher).

Net Debt

-11.33 MEUR

YoY

-67.35%

Last updated:

Net Debt of Circa Group AS is 2023 -11.33 M EUR. Net Debt of Circa Group AS was 2022 -34.71 M EUR. It decreases by -67.35% higher compared to the previous year.

The Circa Group AS Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2020
-4.72 M EUR
Jan 1, 2021
-44.39 M EUR
Jan 1, 2022
-34.71 M EUR
Jan 1, 2023
-11.33 M EUR
The Circa Group AS Net Debt history
YEARNet DebtYoY
-11.33 MEUR-67.35%
-34.71 MEUR-21.80%
-44.39 MEUR+839.57%
-4.72 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Circa Group AS Stock analysis

What does Circa Group AS do? Circa Group AS produces biochemicals through its proprietary Furacell process, converting biomass into advanced bio-based chemicals. The company's product portfolio includes Cyrene, a bio-solvent derived from Levoglucosenone (LGO), which serves as a greener alternative to traditional toxic solvents in paints, coatings, battery, and textile applications. The company develops flavorings, biopolymers, and bio-solvents under development, with Cyrene being a key product for industrial processes requiring safer solvents. Subsidiaries such as Circa Sustainable Chemicals Pty Ltd, Circa Sustainable Chemicals SAS, Circa Sustainable Chemicals BV, and Circa Group Pty. Ltd. support the company's global operations. Circa Group AS sells its biochemical products primarily to industries requiring sustainable chemical solutions, including paint and coating manufacturers, battery producers, and textile companies. The company's focus on eco-friendly solvents like Cyrene targets markets seeking safer alternatives to conventional toxic solvents. By leveraging its Furacell process, Circa Group AS differentiates its offerings as advanced bio-based chemicals with improved environmental and performance profiles. The company's revenue streams are derived from the sale of its biochemical products, particularly Cyrene and other bio-solvents, to industrial clients across multiple sectors. Its subsidiaries facilitate regional market access and operational efficiency, supporting the commercialization of its proprietary technology. As a biotechnology firm, Circa Group AS monetizes its proprietary Furacell process by converting biomass into high-demand sustainable chemicals. Circa Group AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Circa Group AS stock

Net Debt of Circa Group AS is -11.33 M EUR in 2023.

Net Debt of Circa Group AS changed from -34.71 M EUR to -11.33 M EUR, representing a -67.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt Circa Group AS since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's Circa Group AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Circa Group AS

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Circa Group AS